Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Constellation Pharmaceuticals Inc (CNST)

Constellation Pharmaceuticals Inc (CNST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
MorphoSys to Complete Transformational Acquisition of Constellation Pharmaceuticals, Bolstering Its Position in Hematology-Oncology ACCESS Newswire - Thu Jul 15, 2021

Company Announces Successful Completion of Tender Offer Moves Forward with Strategic Funding Partnership with Royalty Pharma PLANEGG / MUNICH, GERMANY / ACCESSWIRE / July 15, 2021 / MorphoSys AG (FSE:MOR;...

MOR : 18.96 (+2.43%)
CNST : 33.99 (+0.06%)
MorphoSys Announces Expiration of the Hart-Scott-Rodino Waiting Period for Acquisition of Constellation Pharmaceuticals ACCESS Newswire - Thu Jul 1, 2021

MUNICH, GERMANY and WILMINGTON, DE / ACCESSWIRE / July 1, 2021 / MorphoSys AG (FSE:MOR) (NASDAQ:MOR) ("MorphoSys") today announced the expiration of the waiting period under the Hart-Scott-Rodino Antitrust...

MOR : 18.96 (+2.43%)
CNST : 33.99 (+0.06%)
SHAREHOLDER ALERT: Halper Sadeh LLP Investigates CORE, MMAC, CNST, SLCT; Shareholders are Encouraged to Contact the Firm ACCESS Newswire - Mon Jun 28, 2021

NEW YORK, NY / ACCESSWIRE / June 28, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Core-Mark Holding Company, Inc. (NASDAQ:CORE) concerning...

CORE : 45.65 (-0.76%)
CNST : 33.99 (+0.06%)
MMAC : 27.77 (+0.04%)
SLCT : 18.88 (-2.43%)
INVESTIGATION ALERT: Halper Sadeh LLP Investigates EBSB, FMBI, CNST, SLCT; Shareholders are Encouraged to Contact the Firm ACCESS Newswire - Thu Jun 24, 2021

NEW YORK, NY / ACCESSWIRE / June 24, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Meridian Bancorp, Inc. (NASDAQ:EBSB) concerning potential...

CNST : 33.99 (+0.06%)
EBSB : 24.15 (-2.03%)
SLCT : 18.88 (-2.43%)
FMBI : 21.51 (+2.77%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates CNST, MDP, FMBI, AVCO; Shareholders are Encouraged to Contact the Firm ACCESS Newswire - Mon Jun 21, 2021

NEW YORK, NY / ACCESSWIRE / June 21, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Constellation Pharmaceuticals, Inc. (NASDAQ:CNST)...

CNST : 33.99 (+0.06%)
MDP : 59.07 (+0.12%)
FMBI : 21.51 (+2.77%)
AVCO : 0.5259 (-16.52%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates DSSI, FMBI, CNST, SLCT; Shareholders are Encouraged to Contact the Firm ACCESS Newswire - Thu Jun 10, 2021

NEW YORK, NY / ACCESSWIRE / June 10, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Diamond S Shipping Inc. (NYSE:DSSI) concerning potential...

CNST : 33.99 (+0.06%)
DSSI : 9.69 (+2.00%)
SLCT : 18.88 (-2.43%)
FMBI : 21.51 (+2.77%)
MorphoSys AG to Acquire Constellation Pharmaceuticals and Enter into Strategic Funding Partnership with Royalty Pharma ACCESS Newswire - Wed Jun 2, 2021

MUNICH, GERMANY and CAMBRIDGE, MA / ACCESSWIRE / June 2, 2021 / MorphoSys AG (FSE:MOR) (NASDAQ:MOR) ("MorphoSys"), announces today that it has entered into a definitive agreement with Constellation Pharmaceuticals,...

MOR : 18.96 (+2.43%)
RPRX : 39.15 (-1.14%)
CNST : 33.99 (+0.06%)

Barchart Exclusives

Is This Dividend Stock a Buy for 2026 After Rising 265% in 2025? Barchart - Thu Dec 4, 6:30PM CST
Anglogold Ashanti shares have soared this year amid a spike in gold prices. While the shares might take a breather for now, it is a buy-on-the-dip candidate for 2026. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot